Related Experiment Video
Updated: Jan 10, 2026
11:14
Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
18.8K
AND Logic Gate-Based Dual-Specificity DNA Circuit for Isothermal HBV rcDNA Detection
Jingyi Si1,2, Yifan Gao1,2, Zhenzhou Yang3
1Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai 200437, China.
JACS Au
|November 28, 2025
Summary
This study presents a novel DNA circuit for detecting Hepatitis B virus (HBV) DNA, overcoming challenges posed by complex HBV mutations. The assay offers high sensitivity and specificity for improved HBV DNA testing.
Area of Science:
- Biochemistry
- Molecular Biology
- Medical Diagnostics
Background:
- Quantitative analysis of Hepatitis B virus (HBV) DNA is crucial for disease management and patient prognosis.
- Complex HBV genome variations, including adjacent mutations and degeneracy in the genetic code, pose significant challenges for accurate detection and specificity.
Purpose of the Study:
- To develop a highly sensitive and specific DNA-based assay for detecting HBV DNA.
- To address the limitations of existing methods in identifying complex HBV mutations and single-base mismatches.
Main Methods:
- An AND logic gate-based dual-specificity DNA circuit was designed, integrating toehold-mediated DNA strand displacement and RNase H cleavage.
- A specifically designed probe with identification and amplification elements was utilized for HBV DNA detection.
Main Results:
- The DNA circuit achieved a low limit of detection (29.11 fM), demonstrating enhanced sensitivity.
- High specificity was observed, enabling the discrimination of adjacent single-base mismatches.
- The assay performed excellently on clinical samples, validating its real-world applicability.
Conclusions:
- The developed DNA circuit offers a sensitive and specific method for HBV DNA detection.
- This innovative assay holds promise for advancing point-of-care testing for Hepatitis B virus.
- The approach effectively addresses the challenges associated with HBV genetic complexity.
